Dr Alan Stephen Catalyst Scientist
Alan Stephen is a Catalyst Scientist working on Hydrogen technologies at Johnson Matthey. After completing his Biochemistry degree at the University of Oxford, he moved to the University of Birmingham to do a PhD. Here, he worked on synthesising nanoparticles from bacteria for use as catalysts in fuel cells. He then moved to Johnson Matthey as a catalyst scientist for both fuel cells and electrolysers. He manages the transfer of promising research catalysts for use in commercial products. With this role, he works with multiple functions including research, commercial, operations and others. Alongside his day job, he is also part of Pride in JM, an LGBT+ specific employee resource group that promotes LGBT+ inclusivity across the business. He works with the D&I team to organise global events, consult on policies, and deliver D&I training to interest groups.
nano merics Precision Medicines
Dr Ilona Kubajewska MRSC Senior Development Scientist
Ilona has ~15 years of experience in multidisciplinary and translational pharmaceutical and biomedical research and is an award-winning scientist (13 awards, grants and scholarships) with track record of >40 scientific research outputs, including publications in scientific journals, posters and oral presentations at international conferences, patents. Ilona majored in Biotechnology from University of Warsaw, Poland (BSc, MSc), then completed her PhD in Biomedical Sciences at University of Nottingham, UK. Following visiting research fellowships in Germany and USA, she continued her research at postdoctoral level at University College London (UCL School of Pharmacy, UCL Centre for Nanotechnology & Regenerative Medicine), working on nanotechnology applications in oncology, gene therapies, vaccines and immunotherapies, and brain delivery of therapeutic compounds for treatment of neurodegenerative diseases. During that time, she also successfully delivered several R&D consultancy projects for Nanomerics and eventually joined full-time as a Senior Development Scientist in 2021, where she leads various research programmes focussed on preclinical development of nanomedicines.
Made with FlippingBook Learn more on our blog